SLC7A7 Gene

Last updated on: 24.05.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The SLC7A7 gene (SLC7A7 stands for "Solute Carrier Family 7 Member 7") is a protein-coding gene located on chromosome 14q11.2. Alternative splicing results in multiple transcript variants.

General informationThis section has been translated automatically.

The protein encoded by the SLC7A7 gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed by dimerization of the SLC7A7 protein with the heavy subunit transporter protein SLC3A2. The now dimerized transporter protein complex SLC7A7/ SLC3A2 is found in the membranes of epithelial cells, where it transports cationic and large neutral amino acids out of the cell into the extracellular space.

Furthermore, the complex is involved in the sodium-independent uptake of dibasic amino acids and the sodium-dependent uptake of some neutral amino acids. Furthermore, the complex plays a role in nitric oxide synthesis in human umbilical vein endothelial cells (HUVECs) via the transport of L-arginine. It is involved in the transport of L-arginine in monocytes.

Defects in this gene are a cause of "lysinuric protein intolerance (LPI)" lysinuric protein intolerance (LPI; OMIM: 222700), also known as aminoaciduria, hyperdibasic, type 2. In LPI, cationic ('basic') amino acids are excreted more in the urine and reabsorbed less in the intestine. There is concomitant orotaciduria and immunodeficiency.

LiteratureThis section has been translated automatically.

  1. Font-Llitjos M et al. (2009) Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat. Europ J Hum Genet 17: 71-79.
  2. Kato T et al (1982) Renal transport of lysine and arginine in lysinuric protein intolerance. Europ J Pediat 139: 181-184.
  3. Kekomaki M et al (1968) Familial protein intolerance with deficient transport of basic amino acids. Report on an adult patient with chronic hyperammonemia Acta Med Scand 183: 357-359.
  4. Noguchi A et al. (2019) Overview of symptoms and treatment for lysinuric protein intolerance. J Hum Genet 64:849-858.

Last updated on: 24.05.2022